Optimizing duodenal tissue acquisition for mechanistic studies of duodenal ablation in type 2 diabetes
Open Access
- 16 December 2024
- journal article
- research article
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 13 (CP) , a25032135
Abstract
Histological analysis of regular duodenal biopsies to study morphologic changes after duodenal ablation for type 2 diabetes (T2D) and metabolic syndrome is hampered by variability in tissue orientation. We designed an optimized tissue acquisition protocol using duodenal cold snare resections to create tissue microarrays (TMAs) and to allow for single-cell RNA sequencing (scRNA-seq).The open-label DIRECT study included patients undergoing an upper gastrointestinal interventional endoscopy for non-duodenal indications. All underwent one ot two single-piece duodenal cold snare resections. Endpoints were safety, adequate histological orientation of specimen and TMA, and tissue dissociation quality for scRNA-seq. The optimized tissue acquisition protocol was validated in a duodenal ablation study, EMINENT-2.In DIRECT, nine patients were included in whom a total of 16 cold snare resections were obtained. No severe adverse events (SAEs) occurred. Eighty percent of specimens and corresponding TMAs showed optimal tissue orientation. Further improvement was achieved by reducing tissue damage during endoscopic retrieval and improving histologic evaluation by eliminating ink use and pinning the tissue on cork. High-quality tissue dissociation scores for scRNA-seq were achieved in 13 of 18 samples (72%). In EMINENT-2, 38 cold snares were obtained without SAEs, histopathologic analysis showed good orientation in all samples, and dissociation scores for scRNA-seq were qualified in 35/38 (92%) samples.Duodenal cold snare resection is safe and can provide high-quality tissue for optimally oriented TMAs and high-quality tissue dissociation scores for scRNA-seq (Clinicaltrials.gov, NCT06333093, NCT05984238). This approach will allow mechanistic studies about the effects of duodenal ablation on metabolic syndrome and T2D.Keywords
This publication has 15 references indexed in Scilit:
- Recellularization via electroporation therapy of the duodenum combined with glucagon-like peptide-1 receptor agonist to replace insulin therapy in patients with type 2 diabetes: 12-month results of a first-in-human studyGastrointestinal Endoscopy, 2024
- Insulin sensitivity and beta cell function after duodenal mucosal resurfacing: an open-label, mechanistic, pilot studyGastrointestinal Endoscopy, 2024
- Cold snare polypectomy for duodenal adenomas in familial adenomatous polyposis: a prospective international cohort studyEndoscopy International Open, 2023
- Cold snare polypectomy for superficial non-ampullary duodenal epithelial tumor: a prospective clinical trial (pilot study)Surgical Endoscopy, 2021
- Duodenal mucosal resurfacing combined with glucagon-like peptide-1 receptor agonism to discontinue insulin in type 2 diabetes: a feasibility studyGastrointestinal Endoscopy, 2021
- Endoscopic management of ampullary tumors: European Society of Gastrointestinal Endoscopy (ESGE) GuidelineEndoscopy, 2021
- Piecemeal cold snare polypectomy versus conventional endoscopic mucosal resection for large sessile serrated lesions: a retrospective comparison across two successive periodsGut, 2020
- Small intestinal physiology relevant to bariatric and metabolic endoscopic therapies: Incretins, bile acid signaling, and gut microbiomeTechniques and Innovations in Gastrointestinal Endoscopy, 2020
- Colorectal polypectomy and endoscopic mucosal resection (EMR): European Society of Gastrointestinal Endoscopy (ESGE) Clinical GuidelineEndoscopy, 2017
- Removal of small colorectal polyps in anticoagulated patients: a prospective randomized comparison of cold snare and conventional polypectomyGastrointestinal Endoscopy, 2014